Physician profile
Malcolm E Musgrave
NPI 1124047394
$1,647.85
in general payments reported to CMS, 2019-2025
12 companies · $143 in 2025
The $143 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.90 · 2020: $15.61 · 2021: $171 · 2022: $574 · 2023: $345 · 2024: $357 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $671 · Gift: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $671.27 |
| Gift | $174.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $733.45 | 2021-2023 | Opalescence |
| Dentsply Sirona INC | $356.95 | 2021-2024 | Astra Tech Implant System, Tph Spectra Universal Composite Restorative Low Viscosity, Cerec |
| Orapharma, A Division of Bausch Health US, LLC | $269.48 | 2020-2025 | Arestin, Ossix Plus |
| Nobel Biocare USA | $84.98 | 2019-2022 | |
| Patterson Companies, INC. | $65.66 | 2022-2025 | |
| A-Dec, INC. | $33.70 | 2023 | |
| Solventum Corporation | $22.96 | 2024 | Vanish Varnish, 3m Relyx, 3m Espe Filtek Supreme Ultra Universal Restorative |
| Sprintray INC | $21.31 | 2025 | |
| Zimvie INC. | $19.87 | 2022 | |
| Colgate Oral Pharmaceuticals, INC. | $15.30 | 2021 | |
| Straumann USA LLC | $13.15 | 2023 | |
| Elevate Oral Care | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malcolm Musgrave listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.